| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |